The DTx market has grown more than 50% over the last 3 years, with many new technologies entering the market. Although confidence in DTx among health systems is on the rise, wide scale adoption is still lagging. In this panel, Syneos Health will present original research showing payers are concerned about DTx’s real-world utility, as well as existing pricing and payment models. The panel will explore current coverage trends in the U.S. and Europe, examine specific case studies in which DTx developers have run into hurdles, and sketch out what is required to make a more persuasive case to payers. Find out more here.
You are here: / / Digital Therapeutics and Payers